Skip to content

New 75mg darunavir tablet approved by FDA for use by HIV-positive children

A ‘functional cure’?

The return of treatment interruptions?

Can we create ‘elite controllers’?

Enhanced Trofile assay better at identifying HIV tropisms, only slight impact on virologic outcomes

Once-daily darunavir/ritonavir may be an option for some treatment-experienced patients

Darunavir European license extended to all treatment-experienced

Raltegravir resistance patterns becoming clearer

Vicriviroc: long-term safety concerns over cancers dispelled